Akebia Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018 - 2014
Market Capitalization	280	234	106	395	405	752	Upgrade
Market Cap Growth	271.08%	120.08%	-73.16%	-2.30%	-46.16%	138.24%	Upgrade
Enterprise Value	279	234	111	377	257	707	Upgrade
PE Ratio	-	-4.50	-1.13	-1.40	-1.05	-2.69	Upgrade
PS Ratio	1.51	1.20	0.36	1.87	1.37	2.24	Upgrade
PB Ratio	-14.06	-7.64	20.30	5.34	1.63	1.90	Upgrade
P/FCF Ratio	-15.16	-9.99	-1.45	-1.56	-3.66	-2.85	Upgrade
P/OCF Ratio	-15.16	-9.99	-1.45	-1.56	-3.67	-2.92	Upgrade
EV/Sales Ratio	1.49	1.20	0.38	1.78	0.87	2.11	Upgrade
EV/EBITDA Ratio	37.96	-57.90	-2.56	-1.67	-0.75	-2.82	Upgrade
EV/EBIT Ratio	-10.51	-5.11	-1.41	-1.44	-0.68	-2.46	Upgrade
EV/FCF Ratio	-14.99	-10.02	-1.51	-1.49	-2.32	-2.68	Upgrade
Debt / Equity Ratio	-1.39	-1.43	18.17	1.77	0.49	0.26	Upgrade
Debt / EBITDA Ratio	5.15	-10.78	-2.20	-0.58	-0.35	-0.41	Upgrade
Debt / FCF Ratio	-1.49	-1.87	-1.30	-0.52	-1.09	-0.39	Upgrade
Quick Ratio	1.03	0.82	1.01	0.77	1.58	0.90	Upgrade
Current Ratio	1.70	1.18	1.43	1.04	1.99	1.49	Upgrade
Asset Turnover	0.78	0.77	0.63	0.36	0.41	0.41	Upgrade
Interest Coverage	-5.18	-7.61	-5.01	-13.15	-42.38	-	Upgrade
Return on Equity (ROE)	138.70%	186.80%	-350.60%	-188.10%	-115.60%	-57.40%	Upgrade
Return on Assets (ROA)	-18.00%	-20.60%	-20.40%	-47.60%	-54.00%	-34.10%	Upgrade
Return on Capital (ROIC)	-300.73%	-329.75%	-77.40%	-128.87%	-102.50%	-57.48%	Upgrade
Earnings Yield	-15.21%	-22.23%	-88.77%	-71.32%	-95.09%	-37.20%	Upgrade
FCF Yield	-8.93%	-10.01%	-69.03%	-63.99%	-27.35%	-35.13%	Upgrade
Buyback Yield / Dilution	-10.93%	-2.56%	-10.14%	-19.85%	-16.95%	-104.00%	Upgrade
Total Shareholder Return	-10.93%	-2.56%	-10.14%	-19.85%	-16.95%	-104.00%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).